That being said the most often place I have seen this is within manga itself, so this maybe the incidence rate is actually low and the authors who draw this into their series are either traumatised or just passing along a story!
816 karma · joined July 20, 2015
That being said the most often place I have seen this is within manga itself, so this maybe the incidence rate is actually low and the authors who draw this into their series are either traumatised or just passing along a story!
I've been self hosting it for a number of years now and have never had to think about it ever again - it works, has clients for all my platforms, never had any issues.
So yes, they should be providing an office suite whether that be Office365/ Libre Office / etc.
I'm sure veracrypt on the cheap drive works very well, but I dont want to think about usb drives ever again so if I can make the problem go away (and its the customer/company paying for it) i'll buy the product with off the shelf capabilities.
To be slightly more charitable, this is a sensible move as at least this way Atlassian can control the end user experience and (perhaps!) have it not be utter trash. Far easier for them to manage this way.
I hate this kind of behaviour from my tools - it feels like I am constantly being watched for when I "slip" and can be charged more without recourse. If you are going to use this behavior, provide a switch to enable hard limits on usage so a user cannot blunder unto having their budget blown by accident.
Edit: Also, why does the CEO have direct access to cancel user accounts and send them direct messages? Surely they have more important things to do?
At a time when writing is being undervalued and turned into "content" grist for the mill, the last thing I want to see is writing guided by an "AI" down the same old pathways.
Better data aggregation is desperately needed in medicine and sadly I think the creator has walked face first into the horror of cost merely to access clinical trials. Plus, the cost of paying contractors to extract the actually useful information from those trials.
These are key reasons why Open Science and Open Data are so critical, to produce tools like this one. Sadly I don't think there is a "Startup" level of money available for it even so.